InsiderClue
Stocks · Technology · Laboratory Analytical Instruments

Nautilus Biotechnology, Inc.

NAUT Clue Score32
United States Fiscal year ends December CIK 0001808805
$2.25 +23.63% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.25 −58.64% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 10 Jun 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Net income
Fiscal year 2020Net income−15.6EPS, diluted−0.54Fiscal year 2021Net income−50.3EPS, diluted−0.60Fiscal year 2022Net income−57.9EPS, diluted−0.46Fiscal year 2023Net income−63.7EPS, diluted−0.51Fiscal year 2024Net income−70.8EPS, diluted−0.56Fiscal year 2025Net income−59.0EPS, diluted−0.47
FY2020FY2021FY2022FY2023FY2024FY2025
Net income −15.6 −50.3 −57.9 −63.7 −70.8 −59.0
Growth
EPS, diluted −0.54 −0.60 −0.46 −0.51 −0.56 −0.47

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−14.0Capital expenditure−0.9Free cash flow−14.9Fiscal year 2021Operating cash flow−39.2Capital expenditure−2.3Free cash flow−41.5Fiscal year 2022Operating cash flow−45.8Capital expenditure−2.3Free cash flow−48.1Fiscal year 2023Operating cash flow−51.7Capital expenditure−2.4Free cash flow−54.2Fiscal year 2024Operating cash flow−59.1Capital expenditure−2.1Free cash flow−61.3Fiscal year 2025Operating cash flow−50.7Capital expenditure−1.3Free cash flow−52.0
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −14.0 −39.2 −45.8 −51.7 −59.1 −50.7
Capital expenditure −0.9 −2.3 −2.3 −2.4 −2.1 −1.3
Free cash flow −14.9 −41.5 −48.1 −54.2 −61.3 −52.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash36.6Shareholders’ equity−29.7Fiscal year 2021Cash185.6Shareholders’ equity363.6Fiscal year 2022Cash114.5Shareholders’ equity314.9Fiscal year 2023Cash19.4Shareholders’ equity265.4Fiscal year 2024Cash27.6Shareholders’ equity208.7Fiscal year 2025Cash12.4Shareholders’ equity157.0
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 36.6 185.6 114.5 19.4 27.6 12.4
Shareholders’ equity −29.7 363.6 314.9 265.4 208.7 157.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
12.4 29.4 37.7 47.3 50.5 41.1
3.3 21.1 25.9 28.9 31.0 25.7
0.0 0.0 0.0 0.0 0.0 0.0
−15.6 −50.3 −57.9 −63.7 −70.8 −59.0
Growth
Per share
−0.54 −0.60 −0.46 −0.51 −0.56 −0.47
−0.54 −0.60 −0.46 −0.51 −0.56 −0.47
Growth
29.1 84.5 124.6 124.9 125.4 126.3
29.1 84.5 124.6 124.9 125.4 126.3
Growth +190.4% +47.5% +0.3% +0.4% +0.7%

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 6 of 6 years on file.